NTLA Institutional Ownership
Intellia Therapeutics, Inc.
Latest close $10.97 as of Aug 5, 2026
NTLA institutional ownership at a glance
Follow Intellia Therapeutics, Inc. institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: Goldman Sachs Group filed Schedule 13G amendment on Feb 12, 2026, reporting 3.2K shares and 2.70% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating across 1 comparable institution.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 4 filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Goldman Sachs Group CIK0000886982 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Schedule 13G amendment | Earliest Schedule 13G amendment found | 3.2K | 2.70% | $8.99 | $11.62 | $10.97 |
| State Street CIK0000093751 | Dec 31, 2025 observed Feb 9, 2026 filed · 40d Initial Schedule 13G | Initial Schedule 13G | 6.4M +1.9M | 12.00% 0.00 pts | $8.99 | $12.49 | $10.97 |
| State Street CIK0000093751 | Mar 31, 2025 observed May 13, 2025 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 4.5M | 12.00% | $7.11 | $8.32 | $10.97 |
Related research
Compare NTLA with other securities showing similar institutional activity or recent accumulation across several tracked institutions.